Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hepatoblastoma | 9 | 2023 | 90 | 2.110 |
Why?
|
Gastrointestinal Stromal Tumors | 4 | 2016 | 616 | 1.050 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2016 | 961 | 0.850 |
Why?
|
Adrenal Gland Neoplasms | 3 | 2022 | 730 | 0.830 |
Why?
|
Bupivacaine | 2 | 2018 | 432 | 0.790 |
Why?
|
Intestinal Obstruction | 3 | 2023 | 432 | 0.770 |
Why?
|
Aptamers, Nucleotide | 1 | 2023 | 163 | 0.770 |
Why?
|
Peritoneal Dialysis | 2 | 2013 | 161 | 0.760 |
Why?
|
Liver Neoplasms | 10 | 2023 | 4353 | 0.740 |
Why?
|
Splenectomy | 3 | 2020 | 390 | 0.700 |
Why?
|
Ovariectomy | 3 | 2019 | 611 | 0.680 |
Why?
|
Child | 67 | 2024 | 80564 | 0.660 |
Why?
|
Anesthetics, Local | 2 | 2018 | 1015 | 0.620 |
Why?
|
Ovarian Neoplasms | 5 | 2021 | 4900 | 0.610 |
Why?
|
Rectal Diseases | 1 | 2019 | 141 | 0.590 |
Why?
|
Drug Delivery Systems | 2 | 2023 | 2207 | 0.560 |
Why?
|
Neoplasms, Second Primary | 2 | 2019 | 1050 | 0.550 |
Why?
|
Certification | 1 | 2020 | 416 | 0.550 |
Why?
|
Bone Neoplasms | 3 | 2024 | 2567 | 0.550 |
Why?
|
Myasthenia Gravis | 2 | 2017 | 214 | 0.550 |
Why?
|
Thymectomy | 1 | 2017 | 200 | 0.520 |
Why?
|
Osteosarcoma | 3 | 2024 | 909 | 0.510 |
Why?
|
Adrenal Cortex Neoplasms | 2 | 2021 | 161 | 0.490 |
Why?
|
Liposomes | 1 | 2018 | 788 | 0.470 |
Why?
|
Preoperative Care | 5 | 2019 | 2267 | 0.440 |
Why?
|
Child, Preschool | 38 | 2024 | 42500 | 0.430 |
Why?
|
Renal Insufficiency | 2 | 2021 | 804 | 0.400 |
Why?
|
Rectum | 2 | 2009 | 896 | 0.400 |
Why?
|
Infant | 32 | 2024 | 36386 | 0.400 |
Why?
|
Hernia, Inguinal | 3 | 2021 | 224 | 0.390 |
Why?
|
Pediatrics | 4 | 2020 | 3606 | 0.390 |
Why?
|
Spleen | 1 | 2018 | 2296 | 0.390 |
Why?
|
Survivors | 4 | 2023 | 2372 | 0.380 |
Why?
|
Catheters, Indwelling | 2 | 2021 | 438 | 0.380 |
Why?
|
Catheterization | 2 | 2016 | 1425 | 0.380 |
Why?
|
Gastrectomy | 1 | 2016 | 694 | 0.380 |
Why?
|
General Surgery | 2 | 2014 | 1722 | 0.370 |
Why?
|
Adolescent | 39 | 2024 | 88835 | 0.370 |
Why?
|
Polyglycolic Acid | 1 | 2012 | 406 | 0.350 |
Why?
|
Sutures | 1 | 2012 | 284 | 0.340 |
Why?
|
Analgesia | 1 | 2014 | 461 | 0.340 |
Why?
|
Pancreatic Neoplasms | 4 | 2021 | 5444 | 0.340 |
Why?
|
Rectovaginal Fistula | 1 | 2009 | 12 | 0.340 |
Why?
|
Neoplasms | 9 | 2023 | 22340 | 0.330 |
Why?
|
Intestinal Atresia | 1 | 2009 | 69 | 0.320 |
Why?
|
Pylorus | 1 | 2009 | 86 | 0.320 |
Why?
|
Situs Inversus | 1 | 2009 | 63 | 0.320 |
Why?
|
Tibial Arteries | 1 | 2009 | 60 | 0.310 |
Why?
|
Focal Nodular Hyperplasia | 1 | 2008 | 29 | 0.310 |
Why?
|
Urinary Bladder Diseases | 1 | 2009 | 166 | 0.310 |
Why?
|
Femoral Neoplasms | 1 | 2009 | 85 | 0.310 |
Why?
|
Splenic Diseases | 2 | 2020 | 91 | 0.310 |
Why?
|
Retrospective Studies | 33 | 2024 | 81514 | 0.300 |
Why?
|
Pulmonary Blastoma | 1 | 2008 | 43 | 0.300 |
Why?
|
Mesentery | 1 | 2009 | 199 | 0.300 |
Why?
|
Nanomedicine | 1 | 2011 | 286 | 0.300 |
Why?
|
Humans | 108 | 2024 | 765968 | 0.300 |
Why?
|
Infant, Newborn | 20 | 2021 | 26346 | 0.290 |
Why?
|
Tumor Necrosis Factor-alpha | 11 | 2010 | 4348 | 0.290 |
Why?
|
Abnormalities, Multiple | 3 | 2009 | 1424 | 0.290 |
Why?
|
Cardiac Surgical Procedures | 3 | 2013 | 3675 | 0.290 |
Why?
|
Intestinal Volvulus | 1 | 2009 | 82 | 0.290 |
Why?
|
Neuroblastoma | 2 | 2023 | 1263 | 0.290 |
Why?
|
Choristoma | 1 | 2009 | 206 | 0.290 |
Why?
|
Critical Care | 1 | 2020 | 2712 | 0.290 |
Why?
|
Hypertension, Pulmonary | 1 | 2018 | 1604 | 0.290 |
Why?
|
Self Report | 1 | 2019 | 3770 | 0.290 |
Why?
|
Diseases in Twins | 1 | 2009 | 448 | 0.290 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 9 | 2024 | 11868 | 0.280 |
Why?
|
Soft Tissue Neoplasms | 2 | 2022 | 1165 | 0.270 |
Why?
|
Ureter | 1 | 2009 | 364 | 0.270 |
Why?
|
Lactic Acid | 1 | 2012 | 1137 | 0.270 |
Why?
|
Anal Canal | 1 | 2009 | 376 | 0.270 |
Why?
|
Hypnotics and Sedatives | 1 | 2014 | 1191 | 0.270 |
Why?
|
Apoptosis | 10 | 2005 | 9514 | 0.260 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2008 | 5337 | 0.260 |
Why?
|
Saphenous Vein | 1 | 2009 | 511 | 0.250 |
Why?
|
Guideline Adherence | 1 | 2016 | 2243 | 0.250 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2009 | 290 | 0.250 |
Why?
|
Cause of Death | 2 | 2018 | 3708 | 0.250 |
Why?
|
Breast Neoplasms | 12 | 2010 | 21056 | 0.240 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2009 | 587 | 0.240 |
Why?
|
Lung Neoplasms | 5 | 2024 | 13451 | 0.230 |
Why?
|
Neoplasm Staging | 6 | 2021 | 11206 | 0.230 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2006 | 691 | 0.230 |
Why?
|
Female | 57 | 2024 | 396112 | 0.230 |
Why?
|
Cell Survival | 8 | 2010 | 5747 | 0.230 |
Why?
|
Vagina | 1 | 2009 | 848 | 0.220 |
Why?
|
Stress, Psychological | 1 | 2019 | 4533 | 0.220 |
Why?
|
Prenatal Diagnosis | 2 | 2012 | 1268 | 0.210 |
Why?
|
Vincristine | 5 | 2023 | 1039 | 0.210 |
Why?
|
Liver Transplantation | 3 | 2023 | 2412 | 0.210 |
Why?
|
Pleural Neoplasms | 1 | 2008 | 581 | 0.210 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2005 | 330 | 0.210 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2019 | 5753 | 0.210 |
Why?
|
Male | 50 | 2024 | 363698 | 0.210 |
Why?
|
Protein Kinase C | 2 | 2005 | 1202 | 0.200 |
Why?
|
Intestine, Small | 1 | 2009 | 1214 | 0.200 |
Why?
|
Chemotherapy, Adjuvant | 5 | 2022 | 3537 | 0.200 |
Why?
|
Peritoneal Neoplasms | 1 | 2009 | 703 | 0.200 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 2 | 2021 | 480 | 0.200 |
Why?
|
Young Adult | 15 | 2024 | 59889 | 0.200 |
Why?
|
Sodium Channel Blockers | 1 | 2023 | 170 | 0.200 |
Why?
|
Tetrodotoxin | 1 | 2023 | 244 | 0.190 |
Why?
|
Estrogen Receptor alpha | 4 | 2012 | 578 | 0.190 |
Why?
|
Incidence | 10 | 2021 | 21480 | 0.190 |
Why?
|
Advanced Cardiac Life Support | 1 | 2002 | 80 | 0.190 |
Why?
|
Referral and Consultation | 1 | 2014 | 3615 | 0.190 |
Why?
|
Postoperative Complications | 6 | 2021 | 15747 | 0.180 |
Why?
|
Piperazines | 1 | 2012 | 2549 | 0.180 |
Why?
|
Hernia, Femoral | 1 | 2021 | 18 | 0.180 |
Why?
|
Intensive Care Units | 1 | 2014 | 3800 | 0.180 |
Why?
|
Follow-Up Studies | 12 | 2024 | 39193 | 0.180 |
Why?
|
Paraganglioma | 1 | 2022 | 143 | 0.170 |
Why?
|
Tumor Cells, Cultured | 9 | 2005 | 6113 | 0.170 |
Why?
|
Organic Chemicals | 1 | 2001 | 211 | 0.170 |
Why?
|
Adrenocortical Carcinoma | 1 | 2021 | 87 | 0.170 |
Why?
|
Acute Kidney Injury | 1 | 2012 | 1946 | 0.170 |
Why?
|
Intestines | 1 | 2009 | 1906 | 0.170 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2023 | 2329 | 0.170 |
Why?
|
Appendectomy | 2 | 2020 | 444 | 0.170 |
Why?
|
Wilms Tumor | 1 | 2023 | 379 | 0.170 |
Why?
|
Pheochromocytoma | 1 | 2022 | 323 | 0.170 |
Why?
|
Estrogens | 3 | 2010 | 1529 | 0.170 |
Why?
|
Pyrimidines | 1 | 2012 | 3047 | 0.160 |
Why?
|
Hernia, Umbilical | 1 | 2021 | 102 | 0.160 |
Why?
|
Antibiotic Prophylaxis | 1 | 2005 | 644 | 0.160 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2002 | 634 | 0.160 |
Why?
|
Prognosis | 12 | 2022 | 29922 | 0.160 |
Why?
|
Pain | 1 | 2014 | 5077 | 0.160 |
Why?
|
Chronic Disease | 4 | 2023 | 9347 | 0.160 |
Why?
|
Delayed-Action Preparations | 1 | 2023 | 967 | 0.160 |
Why?
|
Flavones | 2 | 2012 | 67 | 0.160 |
Why?
|
Gallbladder Diseases | 1 | 2020 | 139 | 0.160 |
Why?
|
NF-kappa B | 3 | 2004 | 2485 | 0.160 |
Why?
|
Biopsy | 6 | 2020 | 6763 | 0.160 |
Why?
|
Sulfones | 1 | 2001 | 447 | 0.150 |
Why?
|
Laparoscopy | 2 | 2020 | 2039 | 0.150 |
Why?
|
Micelles | 1 | 2018 | 188 | 0.150 |
Why?
|
Teratoma | 1 | 2021 | 401 | 0.150 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 2 | 2016 | 368 | 0.150 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2024 | 2024 | 0.150 |
Why?
|
Nevus, Epithelioid and Spindle Cell | 1 | 2019 | 67 | 0.150 |
Why?
|
Cholecystectomy | 1 | 2020 | 407 | 0.150 |
Why?
|
Resource Allocation | 1 | 2020 | 354 | 0.140 |
Why?
|
Testicular Diseases | 1 | 2018 | 72 | 0.140 |
Why?
|
Epoprostenol | 1 | 2018 | 246 | 0.140 |
Why?
|
Risk Factors | 11 | 2023 | 74840 | 0.140 |
Why?
|
End Stage Liver Disease | 1 | 2022 | 369 | 0.140 |
Why?
|
Anesthetics | 1 | 2023 | 525 | 0.140 |
Why?
|
United States | 14 | 2024 | 72903 | 0.140 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2016 | 9373 | 0.140 |
Why?
|
Hernia, Ventral | 1 | 2021 | 220 | 0.140 |
Why?
|
Radiopharmaceuticals | 2 | 2024 | 2699 | 0.140 |
Why?
|
Colon | 1 | 2005 | 1795 | 0.130 |
Why?
|
Catheterization, Central Venous | 1 | 2021 | 539 | 0.130 |
Why?
|
Cisplatin | 4 | 2021 | 1658 | 0.130 |
Why?
|
Glomus Tumor | 1 | 2017 | 63 | 0.130 |
Why?
|
Bacterial Infections | 1 | 2005 | 1387 | 0.130 |
Why?
|
Survival Analysis | 4 | 2013 | 10070 | 0.130 |
Why?
|
Electron Transport Complex II | 1 | 2016 | 53 | 0.130 |
Why?
|
MAP Kinase Kinase 5 | 2 | 2008 | 10 | 0.130 |
Why?
|
Injections, Intravenous | 1 | 2018 | 1377 | 0.130 |
Why?
|
Membrane Glycoproteins | 2 | 2004 | 3690 | 0.130 |
Why?
|
Nitriles | 1 | 2001 | 982 | 0.130 |
Why?
|
Protein Kinase Inhibitors | 2 | 2012 | 5696 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2016 | 723 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 2 | 2008 | 66 | 0.130 |
Why?
|
Specimen Handling | 1 | 2020 | 704 | 0.120 |
Why?
|
Succinate Dehydrogenase | 1 | 2016 | 147 | 0.120 |
Why?
|
Heart Arrest | 2 | 2022 | 1516 | 0.120 |
Why?
|
Lung Diseases | 2 | 2019 | 1940 | 0.120 |
Why?
|
Infant, Newborn, Diseases | 1 | 2021 | 587 | 0.120 |
Why?
|
Nuclear Receptor Coactivator 2 | 2 | 2006 | 40 | 0.120 |
Why?
|
Survival Rate | 4 | 2024 | 12795 | 0.120 |
Why?
|
Ascitic Fluid | 1 | 2015 | 190 | 0.120 |
Why?
|
Postoperative Hemorrhage | 1 | 2019 | 413 | 0.120 |
Why?
|
Diagnosis, Differential | 5 | 2024 | 12976 | 0.120 |
Why?
|
Societies, Medical | 2 | 2019 | 3956 | 0.120 |
Why?
|
Disease-Free Survival | 4 | 2019 | 6832 | 0.120 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2002 | 1083 | 0.120 |
Why?
|
Siblings | 1 | 2019 | 828 | 0.120 |
Why?
|
Ovarian Diseases | 1 | 2016 | 131 | 0.120 |
Why?
|
Critical Illness | 2 | 2020 | 2744 | 0.120 |
Why?
|
Trans-Activators | 1 | 2004 | 2850 | 0.120 |
Why?
|
Adult | 16 | 2024 | 223044 | 0.120 |
Why?
|
Rats, Sprague-Dawley | 2 | 2018 | 8102 | 0.120 |
Why?
|
Combined Modality Therapy | 3 | 2012 | 8529 | 0.120 |
Why?
|
Treatment Outcome | 13 | 2023 | 65188 | 0.120 |
Why?
|
Hospital Charges | 1 | 2016 | 345 | 0.110 |
Why?
|
Ascites | 1 | 2016 | 336 | 0.110 |
Why?
|
Hepatic Veno-Occlusive Disease | 1 | 2016 | 221 | 0.110 |
Why?
|
Fluorouracil | 3 | 2017 | 1648 | 0.110 |
Why?
|
Teaching | 1 | 2002 | 1169 | 0.110 |
Why?
|
Etoposide | 2 | 2008 | 636 | 0.110 |
Why?
|
Estrogen Receptor Modulators | 2 | 2012 | 58 | 0.110 |
Why?
|
Phorbol Esters | 2 | 2005 | 108 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 2 | 2016 | 6499 | 0.110 |
Why?
|
Heart Defects, Congenital | 4 | 2009 | 4697 | 0.110 |
Why?
|
Plasmapheresis | 1 | 2014 | 205 | 0.110 |
Why?
|
Antihypertensive Agents | 2 | 2023 | 2033 | 0.110 |
Why?
|
Pleural Effusion | 1 | 2016 | 346 | 0.100 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2016 | 791 | 0.100 |
Why?
|
Physicians | 1 | 2011 | 4588 | 0.100 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2015 | 326 | 0.100 |
Why?
|
Wounds and Injuries | 2 | 2003 | 2511 | 0.100 |
Why?
|
Chalcone | 1 | 2012 | 10 | 0.100 |
Why?
|
Poverty | 1 | 2024 | 2714 | 0.100 |
Why?
|
Academies and Institutes | 1 | 2015 | 326 | 0.100 |
Why?
|
Luciferases | 3 | 2004 | 713 | 0.100 |
Why?
|
Biomedical Research | 2 | 2020 | 3458 | 0.100 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 2 | 2004 | 195 | 0.100 |
Why?
|
Skin | 2 | 2019 | 4489 | 0.100 |
Why?
|
Hepatectomy | 2 | 2022 | 589 | 0.100 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 1560 | 0.100 |
Why?
|
Cytodiagnosis | 1 | 2015 | 453 | 0.100 |
Why?
|
Drug Prescriptions | 1 | 2020 | 1662 | 0.090 |
Why?
|
Device Removal | 1 | 2016 | 646 | 0.090 |
Why?
|
Kidney Neoplasms | 2 | 2023 | 4274 | 0.090 |
Why?
|
Sarcoma | 1 | 2022 | 1802 | 0.090 |
Why?
|
Databases, Factual | 2 | 2019 | 8067 | 0.090 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2010 | 2878 | 0.090 |
Why?
|
Doxorubicin | 4 | 2021 | 2230 | 0.090 |
Why?
|
Drainage | 1 | 2016 | 1179 | 0.090 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 440 | 0.090 |
Why?
|
Aftercare | 1 | 2016 | 911 | 0.090 |
Why?
|
Signal Transduction | 8 | 2010 | 23601 | 0.090 |
Why?
|
Positron-Emission Tomography | 2 | 2024 | 6547 | 0.090 |
Why?
|
Genetic Markers | 1 | 2016 | 2601 | 0.090 |
Why?
|
Sickle Cell Trait | 1 | 2010 | 86 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2020 | 1772 | 0.090 |
Why?
|
Cyclophosphamide | 2 | 2008 | 2228 | 0.080 |
Why?
|
Congresses as Topic | 1 | 2015 | 811 | 0.080 |
Why?
|
Anesthesia, Local | 1 | 2012 | 276 | 0.080 |
Why?
|
Polyhydramnios | 1 | 2009 | 41 | 0.080 |
Why?
|
Urogenital Surgical Procedures | 1 | 2009 | 34 | 0.080 |
Why?
|
Cystadenoma, Mucinous | 1 | 2009 | 62 | 0.080 |
Why?
|
Antineoplastic Agents, Phytogenic | 3 | 2002 | 616 | 0.080 |
Why?
|
Gynecomastia | 1 | 2010 | 87 | 0.080 |
Why?
|
Proportional Hazards Models | 2 | 2016 | 12509 | 0.080 |
Why?
|
Rats | 2 | 2018 | 23707 | 0.080 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2014 | 669 | 0.080 |
Why?
|
Chi-Square Distribution | 2 | 2012 | 3432 | 0.080 |
Why?
|
Mesna | 1 | 2008 | 62 | 0.080 |
Why?
|
Tamoxifen | 2 | 2004 | 963 | 0.080 |
Why?
|
Age Factors | 4 | 2018 | 18380 | 0.080 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12056 | 0.080 |
Why?
|
Sarcoma, Synovial | 1 | 2009 | 155 | 0.070 |
Why?
|
Ifosfamide | 1 | 2008 | 233 | 0.070 |
Why?
|
Logistic Models | 2 | 2013 | 13266 | 0.070 |
Why?
|
Surgical Procedures, Operative | 1 | 2019 | 1941 | 0.070 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2004 | 1151 | 0.070 |
Why?
|
Bone Marrow Transplantation | 2 | 2008 | 2729 | 0.070 |
Why?
|
Liver Failure, Acute | 1 | 2009 | 183 | 0.070 |
Why?
|
Time Factors | 6 | 2020 | 40065 | 0.070 |
Why?
|
Estrogen Receptor beta | 2 | 2006 | 171 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2010 | 1410 | 0.070 |
Why?
|
Lung | 2 | 2019 | 10033 | 0.070 |
Why?
|
Melphalan | 1 | 2008 | 425 | 0.070 |
Why?
|
Curriculum | 1 | 2020 | 3782 | 0.070 |
Why?
|
Pneumonectomy | 2 | 2017 | 1128 | 0.070 |
Why?
|
Hospitals, Pediatric | 1 | 2016 | 1846 | 0.070 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2002 | 3646 | 0.070 |
Why?
|
Tissue Donors | 2 | 2022 | 2395 | 0.070 |
Why?
|
Anti-Bacterial Agents | 1 | 2005 | 7478 | 0.060 |
Why?
|
Benzamides | 1 | 2012 | 1377 | 0.060 |
Why?
|
Nanostructures | 1 | 2011 | 548 | 0.060 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2008 | 633 | 0.060 |
Why?
|
Prevalence | 2 | 2021 | 15842 | 0.060 |
Why?
|
Carboplatin | 1 | 2008 | 789 | 0.060 |
Why?
|
Genetic Counseling | 1 | 2009 | 634 | 0.060 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2008 | 691 | 0.060 |
Why?
|
Mesoderm | 1 | 2008 | 679 | 0.060 |
Why?
|
Gene Rearrangement | 1 | 2010 | 1144 | 0.060 |
Why?
|
Apigenin | 1 | 2005 | 17 | 0.060 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2009 | 328 | 0.060 |
Why?
|
Sex Distribution | 1 | 2010 | 2263 | 0.060 |
Why?
|
Transcription, Genetic | 4 | 2010 | 7599 | 0.060 |
Why?
|
Nuclear Receptor Coactivator 3 | 1 | 2004 | 45 | 0.060 |
Why?
|
Nuclear Receptor Coactivator 1 | 1 | 2004 | 42 | 0.060 |
Why?
|
Morbidity | 1 | 2010 | 1749 | 0.060 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2008 | 540 | 0.060 |
Why?
|
Transcription Factors | 1 | 2004 | 12131 | 0.060 |
Why?
|
Cohort Studies | 4 | 2020 | 41649 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3835 | 0.060 |
Why?
|
Age Distribution | 1 | 2010 | 2858 | 0.060 |
Why?
|
Quality Improvement | 1 | 2019 | 3853 | 0.060 |
Why?
|
Infant, Low Birth Weight | 1 | 2009 | 871 | 0.060 |
Why?
|
Sepsis | 1 | 2018 | 2606 | 0.060 |
Why?
|
Receptors, Estrogen | 2 | 2004 | 2242 | 0.060 |
Why?
|
Epithelium | 1 | 2008 | 1599 | 0.060 |
Why?
|
Digestive System Surgical Procedures | 1 | 2009 | 580 | 0.060 |
Why?
|
Cathartics | 1 | 2005 | 129 | 0.050 |
Why?
|
Incidental Findings | 1 | 2008 | 697 | 0.050 |
Why?
|
Prospective Studies | 4 | 2023 | 54802 | 0.050 |
Why?
|
Therapeutic Irrigation | 1 | 2005 | 297 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2002 | 3797 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2010 | 2453 | 0.050 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2008 | 1776 | 0.050 |
Why?
|
Acetyltransferases | 1 | 2004 | 229 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 5 | 2022 | 20659 | 0.050 |
Why?
|
Neuroendocrine Tumors | 1 | 2009 | 654 | 0.050 |
Why?
|
Boston | 1 | 2016 | 9338 | 0.050 |
Why?
|
Leukemia, Radiation-Induced | 1 | 2002 | 36 | 0.050 |
Why?
|
Neoplasm Invasiveness | 1 | 2011 | 3602 | 0.050 |
Why?
|
Hypertension | 1 | 2023 | 8626 | 0.050 |
Why?
|
Response Elements | 1 | 2004 | 307 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 2 | 2009 | 36532 | 0.050 |
Why?
|
Functional Laterality | 1 | 2009 | 2243 | 0.050 |
Why?
|
Syndrome | 1 | 2009 | 3271 | 0.050 |
Why?
|
Antineoplastic Agents | 3 | 2018 | 13648 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2017 | 2921 | 0.050 |
Why?
|
alpha-Fetoproteins | 1 | 2023 | 226 | 0.050 |
Why?
|
Estradiol | 3 | 2012 | 1947 | 0.050 |
Why?
|
Histone Acetyltransferases | 1 | 2004 | 332 | 0.050 |
Why?
|
Louisiana | 1 | 2002 | 104 | 0.050 |
Why?
|
Catecholamines | 1 | 2023 | 383 | 0.050 |
Why?
|
Flavonoids | 1 | 2005 | 448 | 0.050 |
Why?
|
Hospital Mortality | 2 | 2013 | 5343 | 0.050 |
Why?
|
3-Iodobenzylguanidine | 1 | 2022 | 113 | 0.050 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2010 | 2423 | 0.050 |
Why?
|
Quality of Life | 2 | 2022 | 13462 | 0.050 |
Why?
|
Genes, Dominant | 1 | 2004 | 856 | 0.050 |
Why?
|
Mitotane | 1 | 2021 | 20 | 0.050 |
Why?
|
Ultrasonography, Prenatal | 1 | 2009 | 1774 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5508 | 0.050 |
Why?
|
Organizational Case Studies | 1 | 2002 | 299 | 0.050 |
Why?
|
Wound Healing | 1 | 2012 | 2792 | 0.050 |
Why?
|
Enzyme Activation | 2 | 2004 | 3586 | 0.040 |
Why?
|
Resuscitation Orders | 1 | 2003 | 275 | 0.040 |
Why?
|
Gestational Age | 1 | 2009 | 3609 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2002 | 1240 | 0.040 |
Why?
|
Inhibitory Concentration 50 | 1 | 2001 | 461 | 0.040 |
Why?
|
Carcinosarcoma | 1 | 2001 | 106 | 0.040 |
Why?
|
Groin | 1 | 2021 | 106 | 0.040 |
Why?
|
Desmoplastic Small Round Cell Tumor | 1 | 2020 | 33 | 0.040 |
Why?
|
Pancreatectomy | 2 | 2021 | 820 | 0.040 |
Why?
|
Odds Ratio | 1 | 2012 | 9649 | 0.040 |
Why?
|
Oncogene Proteins | 1 | 2004 | 710 | 0.040 |
Why?
|
Melanoma | 1 | 2019 | 5719 | 0.040 |
Why?
|
Organometallic Compounds | 1 | 2024 | 644 | 0.040 |
Why?
|
Neurosurgical Procedures | 1 | 2011 | 2074 | 0.040 |
Why?
|
Carcinogens | 1 | 2002 | 452 | 0.040 |
Why?
|
Reoperation | 2 | 2009 | 4294 | 0.040 |
Why?
|
Cell Line, Tumor | 5 | 2012 | 17075 | 0.040 |
Why?
|
Sphingomyelin Phosphodiesterase | 1 | 2000 | 83 | 0.040 |
Why?
|
Disease Progression | 1 | 2016 | 13632 | 0.040 |
Why?
|
Tissue Banks | 1 | 2020 | 183 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2019 | 5849 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2016 | 7851 | 0.040 |
Why?
|
Abdominal Wall | 1 | 2021 | 166 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15880 | 0.040 |
Why?
|
Adrenalectomy | 1 | 2021 | 344 | 0.040 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2001 | 409 | 0.040 |
Why?
|
Longitudinal Studies | 2 | 2018 | 14751 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7425 | 0.040 |
Why?
|
Carcinoma, Papillary | 1 | 2004 | 788 | 0.040 |
Why?
|
Heart-Assist Devices | 1 | 2009 | 1296 | 0.040 |
Why?
|
Proteomics | 2 | 2010 | 3910 | 0.040 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2009 | 1758 | 0.040 |
Why?
|
Risk Assessment | 2 | 2018 | 24282 | 0.040 |
Why?
|
Radionuclide Imaging | 1 | 2022 | 1978 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2002 | 1831 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2011 | 4034 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2011 | 11022 | 0.040 |
Why?
|
Middle Aged | 8 | 2021 | 223009 | 0.040 |
Why?
|
Genes, Reporter | 1 | 2001 | 1524 | 0.040 |
Why?
|
International Agencies | 1 | 2018 | 240 | 0.030 |
Why?
|
Paclitaxel | 2 | 2001 | 1728 | 0.030 |
Why?
|
Cell Division | 1 | 2004 | 4475 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 2008 | 4528 | 0.030 |
Why?
|
Phosphorylation | 2 | 2006 | 8278 | 0.030 |
Why?
|
North America | 1 | 2020 | 1285 | 0.030 |
Why?
|
Constipation | 1 | 2020 | 568 | 0.030 |
Why?
|
Methotrexate | 1 | 2002 | 1722 | 0.030 |
Why?
|
Rare Diseases | 1 | 2021 | 635 | 0.030 |
Why?
|
Carcinoma, Renal Cell | 1 | 2010 | 3181 | 0.030 |
Why?
|
Ceramides | 3 | 2003 | 201 | 0.030 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2003 | 1002 | 0.030 |
Why?
|
Lymph Node Excision | 1 | 2021 | 1259 | 0.030 |
Why?
|
Prostheses and Implants | 1 | 2021 | 1273 | 0.030 |
Why?
|
Pyridostigmine Bromide | 1 | 2014 | 32 | 0.030 |
Why?
|
Hospitalization | 1 | 2014 | 10808 | 0.030 |
Why?
|
Pathology, Surgical | 1 | 2015 | 147 | 0.030 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2019 | 728 | 0.030 |
Why?
|
Animals | 3 | 2018 | 168764 | 0.030 |
Why?
|
Lower Extremity | 1 | 2022 | 1226 | 0.030 |
Why?
|
Algorithms | 1 | 2014 | 14071 | 0.030 |
Why?
|
Pregnancy | 3 | 2012 | 30260 | 0.030 |
Why?
|
Cleft Palate | 1 | 2019 | 591 | 0.030 |
Why?
|
Camptothecin | 1 | 2017 | 600 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2004 | 3715 | 0.030 |
Why?
|
Canada | 1 | 2018 | 2119 | 0.030 |
Why?
|
Atrophy | 1 | 2018 | 1635 | 0.030 |
Why?
|
Transfection | 3 | 2010 | 5743 | 0.030 |
Why?
|
Nerve Fibers | 1 | 1996 | 705 | 0.030 |
Why?
|
Scoliosis | 1 | 2019 | 789 | 0.020 |
Why?
|
Myelodysplastic Syndromes | 1 | 2002 | 1404 | 0.020 |
Why?
|
Mutation | 1 | 2016 | 30198 | 0.020 |
Why?
|
Radiotherapy | 1 | 2018 | 1494 | 0.020 |
Why?
|
Emergency Service, Hospital | 2 | 2020 | 7875 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2008 | 9249 | 0.020 |
Why?
|
Age of Onset | 1 | 2018 | 3344 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 2003 | 1938 | 0.020 |
Why?
|
Vinculin | 1 | 2010 | 58 | 0.020 |
Why?
|
Esophageal Neoplasms | 1 | 2001 | 1661 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5302 | 0.020 |
Why?
|
Kidney Medulla | 1 | 2010 | 169 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2008 | 9525 | 0.020 |
Why?
|
Spinal Fusion | 1 | 2019 | 1302 | 0.020 |
Why?
|
Operating Rooms | 1 | 2016 | 788 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2895 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2021 | 3454 | 0.020 |
Why?
|
Macaca mulatta | 1 | 1996 | 2341 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 4850 | 0.020 |
Why?
|
Delayed Graft Function | 1 | 2009 | 50 | 0.020 |
Why?
|
Tumor Stem Cell Assay | 1 | 2008 | 116 | 0.020 |
Why?
|
Factor XIII | 1 | 1989 | 58 | 0.020 |
Why?
|
Aprotinin | 1 | 1989 | 92 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26318 | 0.020 |
Why?
|
Gene Expression | 1 | 2001 | 7584 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2008 | 283 | 0.020 |
Why?
|
Temporal Lobe | 1 | 1996 | 1714 | 0.020 |
Why?
|
Hemostasis, Surgical | 1 | 1989 | 127 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 4562 | 0.020 |
Why?
|
Hemochromatosis | 1 | 2009 | 175 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2019 | 10429 | 0.020 |
Why?
|
Blotting, Western | 2 | 2008 | 5020 | 0.020 |
Why?
|
Sternum | 1 | 1989 | 176 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2016 | 1884 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2000 | 4520 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2021 | 3529 | 0.020 |
Why?
|
Length of Stay | 2 | 2019 | 6485 | 0.020 |
Why?
|
Tissue Adhesives | 1 | 1989 | 177 | 0.020 |
Why?
|
Diet | 1 | 2005 | 8086 | 0.020 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2016 | 1188 | 0.020 |
Why?
|
MAP Kinase Kinase 6 | 1 | 2006 | 20 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 18071 | 0.020 |
Why?
|
Thrombin | 1 | 1989 | 602 | 0.020 |
Why?
|
Health Status | 1 | 2018 | 4080 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8501 | 0.020 |
Why?
|
Patient Readmission | 1 | 2019 | 3286 | 0.020 |
Why?
|
Fibrinogen | 1 | 1989 | 895 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5786 | 0.010 |
Why?
|
Chromatography, Liquid | 1 | 2008 | 990 | 0.010 |
Why?
|
Organ Size | 1 | 2009 | 2260 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2008 | 2476 | 0.010 |
Why?
|
Kidney | 1 | 2019 | 7066 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5526 | 0.010 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2010 | 1624 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2012 | 4260 | 0.010 |
Why?
|
Electrocardiography | 2 | 2003 | 6404 | 0.010 |
Why?
|
Benchmarking | 1 | 2009 | 1052 | 0.010 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2010 | 1608 | 0.010 |
Why?
|
Tandem Mass Spectrometry | 1 | 2008 | 1192 | 0.010 |
Why?
|
DNA Methylation | 1 | 2016 | 4424 | 0.010 |
Why?
|
Transportation of Patients | 1 | 2003 | 178 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 8041 | 0.010 |
Why?
|
Glycine-tRNA Ligase | 1 | 2001 | 2 | 0.010 |
Why?
|
Receptors, Laminin | 1 | 2001 | 26 | 0.010 |
Why?
|
Glycogen Synthase Kinases | 1 | 2001 | 40 | 0.010 |
Why?
|
Peptide Elongation Factor 1 | 1 | 2001 | 40 | 0.010 |
Why?
|
Genes, bcl-2 | 1 | 2001 | 119 | 0.010 |
Why?
|
Up-Regulation | 1 | 2010 | 4137 | 0.010 |
Why?
|
Tissue and Organ Procurement | 1 | 2009 | 989 | 0.010 |
Why?
|
Thoracotomy | 1 | 2003 | 369 | 0.010 |
Why?
|
Brain Mapping | 1 | 1996 | 6601 | 0.010 |
Why?
|
Birth Weight | 1 | 2009 | 2121 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2008 | 12768 | 0.010 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2001 | 490 | 0.010 |
Why?
|
Imidazoles | 1 | 2006 | 1162 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2008 | 3421 | 0.010 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2001 | 414 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2000 | 822 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2004 | 1628 | 0.010 |
Why?
|
Cell Death | 1 | 2003 | 1679 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2010 | 17594 | 0.010 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2001 | 679 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2010 | 4392 | 0.010 |
Why?
|
Fibronectins | 1 | 2001 | 719 | 0.010 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2000 | 615 | 0.010 |
Why?
|
Esophagectomy | 1 | 2001 | 477 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2010 | 4913 | 0.010 |
Why?
|
Pancreas | 1 | 2004 | 1700 | 0.010 |
Why?
|
Drug Interactions | 1 | 2001 | 1417 | 0.010 |
Why?
|
DNA Primers | 1 | 2001 | 2825 | 0.010 |
Why?
|
Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate | 1 | 1996 | 36 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 1998 | 591 | 0.010 |
Why?
|
Caspases | 1 | 1998 | 880 | 0.010 |
Why?
|
Aged | 2 | 2020 | 171117 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2000 | 1718 | 0.010 |
Why?
|
Esophagus | 1 | 2001 | 1037 | 0.010 |
Why?
|
Plasmids | 1 | 2000 | 2274 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2010 | 8611 | 0.010 |
Why?
|
Pulmonary Veins | 2 | 1988 | 757 | 0.010 |
Why?
|
Fibroblast Growth Factors | 1 | 2000 | 871 | 0.010 |
Why?
|
Pyridines | 1 | 2006 | 2888 | 0.010 |
Why?
|
Injections | 1 | 1996 | 840 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2011 | 20124 | 0.010 |
Why?
|
Body Mass Index | 1 | 2010 | 13039 | 0.010 |
Why?
|
Auditory Cortex | 1 | 1996 | 364 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1988 | 8923 | 0.010 |
Why?
|
Parietal Lobe | 1 | 1996 | 858 | 0.010 |
Why?
|
Phenotype | 1 | 2008 | 16721 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2000 | 6493 | 0.010 |
Why?
|
Frontal Lobe | 1 | 1996 | 1410 | 0.010 |
Why?
|
Venae Cavae | 1 | 1988 | 38 | 0.000 |
Why?
|
Fibrin Tissue Adhesive | 1 | 1989 | 86 | 0.000 |
Why?
|
Visual Cortex | 1 | 1996 | 1085 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2000 | 10729 | 0.000 |
Why?
|
Obesity | 1 | 2010 | 13076 | 0.000 |
Why?
|
Models, Biological | 1 | 2003 | 9443 | 0.000 |
Why?
|
Cell Line | 1 | 2000 | 15543 | 0.000 |
Why?
|
Neural Pathways | 1 | 1996 | 3085 | 0.000 |
Why?
|
Random Allocation | 1 | 1989 | 2395 | 0.000 |
Why?
|
Heart Valve Prosthesis | 1 | 1972 | 1466 | 0.000 |
Why?
|
Hepatitis B | 1 | 1989 | 707 | 0.000 |
Why?
|
HIV Seropositivity | 1 | 1989 | 961 | 0.000 |
Why?
|
Drug Combinations | 1 | 1989 | 2077 | 0.000 |
Why?
|
Angiocardiography | 2 | 1972 | 149 | 0.000 |
Why?
|
Emergencies | 1 | 1989 | 1223 | 0.000 |
Why?
|
Aorta | 1 | 1988 | 2028 | 0.000 |
Why?
|
Pulmonary Artery | 1 | 1988 | 1935 | 0.000 |
Why?
|
Hepatitis C | 1 | 1989 | 1597 | 0.000 |
Why?
|
Myocardium | 1 | 1988 | 4760 | 0.000 |
Why?
|
Extracorporeal Circulation | 1 | 1972 | 182 | 0.000 |
Why?
|
Tricuspid Valve | 1 | 1972 | 422 | 0.000 |
Why?
|
Pulmonary Circulation | 1 | 1972 | 741 | 0.000 |
Why?
|
Thromboembolism | 1 | 1972 | 1003 | 0.000 |
Why?
|
Body Height | 1 | 1972 | 1562 | 0.000 |
Why?
|
Heart Valve Diseases | 1 | 1972 | 1030 | 0.000 |
Why?
|
Mitral Valve | 1 | 1972 | 1476 | 0.000 |
Why?
|
Arrhythmias, Cardiac | 1 | 1972 | 2247 | 0.000 |
Why?
|
Aortic Valve | 1 | 1972 | 1968 | 0.000 |
Why?
|
Body Weight | 1 | 1972 | 4622 | 0.000 |
Why?
|
Heart Failure | 1 | 1972 | 11840 | 0.000 |
Why?
|